K-Docz's consortium with Krismas Plastic Surgery and Medibloc won the South Korean government project to build a Korean-type plastic surgery/dentistry cosmetic center in the Sanur Special Economic Zone (SEZ) in Bali, Indonesia.
The 2023 project that helps Korean medicine enter the global market is supported by the Ministry of Health and Welfare and the Korea Health Industry Development Institute.
Kang Byeong-il, Vice President of K-Docz, a group of physicians promoting Korean medicine in foreign countries, expects the Korean plastic surgery/dentistry center to expand exports of Korean medical IT services, pharma products, medical devices, and cosmetics.
Indonesia, the only G20 country in Southeast Asia with rapid economic growth potential, is pushing to make the Sanur SEZ a medical and wellness tourism attraction.
The Indonesian government said it would work with the Mayo Clinic to build an international hospital on Bali island.
The Sanur SEZ is expected to recognize a foreign doctor’s medical license, K-Doc said.


Asian Markets Mixed as RBI Cuts Rates and BOJ Signals Possible Hike
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Disaster or digital spectacle? The dangers of using floods to create social media content
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
IKEA Launches First New Zealand Store, Marking Expansion Into Its 64th Global Market
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO 



